Anyone's hopes for getting a vaccine are going to be delayed at least some.

The FDA finally put out some new guidelines.

The White House had resisted them, but then allowed them to go forward.

The President for weeks has said we'll have a vaccine soon.

He keeps saying soon, and he keeps saying possibly before the election.

I think that's off the table now if you look at the new guidance.

After weeks of this tug of war between the FDA and the White House, the FDA released

new guidelines for coronavirus vaccine developers last week.

When a move the President claimed was a quote, political hit job, the FDA wants at least

two months' worth of data before granting an emergency use authorization in order to

ensure a vaccine is safe.

Here's Dr. Peter Marks.

He's the director of the FDA Center for Biologics Evaluation and Research.

If you look at when most adverse events, the majority of them have occurred by the kind

of a median time, it's somewhere around two to three months.

And so we picked two months as something that was, it was reasonably aggressive, yet also

somewhat kind of in the middle, not too aggressive, not too conservative in the middle.

And while these newly published recommendations all but ensure that a vaccine won't be authorized

before Election Day, it is important to note that the vaccine timeline is not up to the

President alone, or even the FDA for that matter.

Because there is a small secretive group that sees the data before anyone else.

And right now they have one of the most monumental tasks in the world.

...